AngioDynamics, Inc. financials

ANGO CIK 0001275187

Source: EDGAR filings · Built 2026-06-02T02:20:41Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -14.74M -30.68M -3.73M -11.49M 18.91M -21.79M
EBITDA -14.15M -164.72M -20.31M 878.00K -9.37M -143.29M
Working Capital 92.13M 102.10M 79.72M 69.02M 83.30M 101.47M
Net Debt -45.75M -70.14M 10.44M 3.44M -38.43M -44.01M
Gross Margin 53.92% 50.90% 51.44% 52.41% 53.88% 56.89%
Operating Margin -13.66% -63.32% -15.11% -9.00% -12.12% -63.26%
Net Margin -11.62% -60.66% -15.48% -8.40% -10.84% -63.14%
Return on Equity (ROE) -18.58% -89.67% -13.86% -6.25% -7.18% -36.67%
Return on Assets (ROA) -12.13% -58.03% -9.85% -4.80% -5.62% -28.07%
Current Ratio 2.21× 2.12× 1.95× 1.93× 2.45× 2.97×
Debt-to-Equity 0.06× 0.03× 0.15× 0.08× 0.02× 0.02×
Effective Tax Rate 0.11% 3.80% 3.66% 11.36% 12.49% 0.80%
Cash Conversion Ratio 0.30× 0.15× -0.00× 0.27× -0.76× 0.09×
Accruals Ratio -0.09× -0.49× -0.10× -0.04× -0.10× -0.26×
SBC % of Revenue 3.34% 3.46% 3.29% 3.38% 2.96% 2.87%
CapEx Coverage -2.20× -11.18× 0.02× -1.67× 4.64× -2.01×
Free Cash Flow Per Share $-0.36 $-0.76 $-0.09 $-0.29 $0.49 $-0.57

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/FCF 46.89×
FCF Yield 2.13%
EV / EBITDA 879.69×
P/S 1.43× 0.84× 1.11× 2.43× 3.06× 1.47×
P/B 2.29× 1.24× 0.99× 1.81× 2.03× 0.85×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 292.50M 303.91M 338.75M 316.22M 291.01M 264.16M
Revenues 291.01M 264.16M
Cost of Goods and Services Sold 134.79M 149.22M 164.51M 150.49M 134.22M 113.89M
Gross Profit 157.71M 154.70M 174.25M 165.73M 156.79M 150.27M
Research and Development Expense 26.22M 31.51M 29.88M 30.74M 36.39M 29.68M
Operating Expenses 197.66M 401.63M 225.43M 194.20M 192.07M 317.37M
Operating Income (Loss) -39.95M -192.44M -51.18M -28.47M -35.28M -167.10M
Income Tax Expense (Benefit) -39.00K -7.29M -2.00M -3.40M -4.50M -1.35M
Net Income (Loss) Attributable to Parent -33.99M -184.35M -52.44M -26.55M -31.55M -166.79M
Earnings Per Share, Basic $-0.83 $-4.59 $-1.33 $-0.68 $-0.82 $-4.39
Weighted Average Number of Shares Outstanding, Basic 40.85M 40.18M 39.48M 39.01M 38.34M 37.96M
Earnings Per Share, Diluted $-0.83 $-4.59 $-1.33 $-0.68 $-0.82 $-4.39
Weighted Average Number of Shares Outstanding, Diluted 40.85M 40.18M 39.48M 39.01M 38.34M 37.96M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 55.89M 76.06M 44.62M 28.82M 48.16M 54.44M
Assets, Current 168.32M 193.25M 163.54M 143.34M 140.88M 152.91M
Assets 280.14M 317.67M 532.64M 552.75M 561.44M 594.21M
Long-term Debt 0 49.82M 25.00M
Liabilities, Current 76.20M 91.16M 83.83M 74.32M 57.58M 51.45M
Liabilities 97.17M 112.08M 154.34M 128.26M 121.98M 139.34M
Stockholders' Equity Attributable to Parent 182.97M 205.59M 378.30M 424.49M 439.46M 454.87M
Common Stock, Shares, Outstanding 40.99M 40.43M 39.61M 39.17M 38.55M 38.08M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -10.13M -28.16M 78.00K -7.19M 24.09M -14.55M
Payments to Acquire Property, Plant, and Equipment 4.46M 2.52M 3.81M 4.30M 5.19M 7.24M
Net Cash Provided by (Used in) Investing Activities -10.18M 123.72M -9.75M -19.31M -13.71M -63.34M
Payments for Repurchase of Common Stock 1.67M 0 0
Net Cash Provided by (Used in) Financing Activities -255.00K -64.25M 25.42M 7.68M -16.99M -95.24M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (ANGO CIK 0001275187), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MEI

METHODE ELECTRONICS, INC.

TTAM

TITAN AMERICA SA

CSCO

CISCO SYSTEMS, INC.